---
title: "88 Biotech Investors in the San Francisco Bay Area (Nov 2026)"
last_updated: "2026-11-06"
rows: "88"
free_rows: "25"
source: "SEC filings"
canonical: "https://theinvestordatabase.com/lists/biotech-investors-in-san-francisco-bay-area/"
---

# 88 biotech investors in the San Francisco Bay Area

We list 88 biotech investors in the San Francisco Bay Area as of November 2026: each has an SEC filing on file, and the list was last checked on 6 Nov 2026. The cities with the most head offices on this list are San Francisco (27), Palo Alto (16) and Menlo Park (12).

- 88 investors
- 41 with a fund filing or dated deal in the last 12 months
- $100M median fund size on file (SEC Form D, 58 firms)
- 434 named decision-makers on file

## First 25 of 88 biotech investors in the San Francisco Bay Area

| Investor | Type | HQ | Stages (our research) | Focus (our research) | Latest fund or deal | Fund size | Checked | Profile |
|---|---|---|---|---|---|---|---|---|
| Longitude Venture Partners | VC firm | Menlo Park, CA | Growth | Biotech, Healthtech, Medtech | New deal, Jun 2026 | $600M (SEC Form D, 2022) | 2026-11-05 | https://theinvestordatabase.com/investors/longitude-venture-partners/ |
| TCGX | VC firm | Palo Alto, CA |  | Biotech, Healthtech | New fund, Oct 2026 | $600M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/tcgx/ |
| Bison Ventures | VC firm | San Francisco, CA | Pre-seed, Seed, Series A, Series B | Biotech, AI, Healthtech, Energy | New fund, Oct 2026 | $160M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/bison-ventures/ |
| Mitsui & Co. Global Investment, Inc. | Corporate VC | Menlo Park, CA |  | Biotech, Healthtech, AI, Industrial Tech | Portfolio news, Jun 2026 | $142M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/mitsui-co-global-investment-inc/ |
| Felicis | VC firm | Menlo Park, CA | Seed, Series A | Biotech, AI, Developer Tools, Healthtech | New deal, Oct 2026 | $900M (SEC Form D, 2025) | 2026-11-05 | https://theinvestordatabase.com/investors/felicis/ |
| True Ventures | VC firm | Palo Alto, CA | Pre-seed, Seed | Biotech, AI, Fintech, Deep Tech | New fund, Sep 2026 | $800M (SEC Form D, 2022) | 2026-11-04 | https://theinvestordatabase.com/investors/true-ventures/ |
| Lionheart Ventures | VC firm | San Francisco, CA |  | Biotech, Healthtech, Climate Tech, AI | New fund, Aug 2026 | $21M (SEC Form D, 2021) | 2026-11-04 | https://theinvestordatabase.com/investors/lionheart-ventures/ |
| How Women Invest | VC firm | Oakland, CA | Pre-seed, Seed, Series A, Series B | Biotech, Healthtech, AI, B2B | New fund, Sep 2026 | $12M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/how-women-invest/ |
| Future Ventures | VC firm | Los Altos, CA | Seed | Biotech, Healthtech, AI, Energy | New fund, Oct 2026 | $200M (SEC Form D, 2021) | 2026-11-04 | https://theinvestordatabase.com/investors/future-ventures/ |
| Sofinnova | VC firm | Menlo Park, CA |  | Biotech, Healthtech | New fund, Jun 2026 | $550M (SEC Form D, 2024) | 2026-11-04 | https://theinvestordatabase.com/investors/sofinnova/ |
| Breakout Ventures | VC firm | San Francisco, CA | Seed | Biotech, AI, Healthtech, Industrial Tech | New deal, Jun 2026 | $112M (SEC Form D, 2021) | 2026-11-04 | https://theinvestordatabase.com/investors/breakout-ventures/ |
| Refactor Capital | VC firm | Burlingame, CA | Seed | Biotech, AI, Healthtech, Energy | New fund, May 2026 | $50M (SEC Form D, 2021) | 2026-11-04 | https://theinvestordatabase.com/investors/refactor-capital/ |
| Artis | VC firm | San Francisco, CA |  | Biotech, Healthtech, AI, Deep Tech | New fund, Jun 2026 | $300M (SEC Form D, 2022) | 2026-11-04 | https://theinvestordatabase.com/investors/artis/ |
| Suncoast Ventures | VC firm | Walnut Creek, CA | Seed | Biotech, Healthtech, Medtech | New fund, Jul 2026 | $15M (SEC Form D, 2022) | 2026-11-04 | https://theinvestordatabase.com/investors/suncoast-ventures/ |
| DCVC | VC firm | Palo Alto, CA |  | Biotech, Energy, Healthtech, AI | New fund, Oct 2026 | $800M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/dcvc/ |
| Draper Associates | VC firm | San Mateo, CA | Pre-seed, Seed, Series A | Biotech, AI, Fintech, Healthtech | New fund, Oct 2026 | $301M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/draper-associates/ |
| Column Group | VC firm | San Francisco, CA | Pre-seed | Biotech, Healthtech | New deal, Jan 2026 | $600M (SEC Form D, 2022) | 2026-11-04 | https://theinvestordatabase.com/investors/column-group/ |
| 3i Partners | VC firm | Los Altos, CA | Pre-seed, Seed | Biotech, Mobility, Healthtech, Deep Tech | New fund, May 2026 | $24M (SEC Form D, 2025) | 2026-11-05 | https://theinvestordatabase.com/investors/3i-partners-los-altos/ |
| Nanodimension | VC firm | Woodside, CA | Any stage | Biotech, Healthtech, Deep Tech |  | $594M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/nanodimension/ |
| Kapor Capital | VC firm | Oakland, CA | Pre-seed, Seed, Series A | Biotech, Edtech, Fintech, Healthtech | New deal, Jun 2026 | $125M (SEC Form D, 2021) | 2026-11-05 | https://theinvestordatabase.com/investors/kapor-capital/ |
| THP | VC firm | San Francisco, CA | Growth | Biotech, Healthtech, Industrial Tech, Medtech | Portfolio news, Apr 2026 | $79M (SEC Form D, 2022) | 2026-11-05 | https://theinvestordatabase.com/investors/thp/ |
| Andreessen Horowitz (a16z) | VC firm | Menlo Park, CA | Seed, Series A, Series B, Growth | Biotech, AI, Defense Tech, Healthtech | New fund, Aug 2026 |  | 2026-11-04 | https://theinvestordatabase.com/investors/andreessen-horowitz-a16z/ |
| Phoenix Venture Partners | VC firm | San Mateo, CA | Seed | Biotech, AI, Healthtech, Energy | Portfolio news, Jul 2026 | $109M (SEC Form D, 2021) | 2026-11-05 | https://theinvestordatabase.com/investors/phoenix-venture-partners/ |
| Pear Ventures | VC firm | Menlo Park, CA | Pre-seed, Seed | Biotech, AI, Fintech, Healthtech | New fund, Oct 2026 | $410M (SEC Form D, 2022) | 2026-11-04 | https://theinvestordatabase.com/investors/pear-ventures/ |
| Frazier Life Sciences | VC firm | Palo Alto, CA | Pre-seed, Seed, Series A, Series B, Growth | Biotech, Healthtech | New fund, Mar 2025 | $7.0B (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/frazier-life-sciences/ |

You are seeing 25 of 88. The full list adds 63 more investors and 434 named decision-makers.

Get all 88 investors and 434 named contacts, $49, one-time: https://theinvestordatabase.com/buy/list/biotech-investors-in-san-francisco-bay-area
This page: https://theinvestordatabase.com/lists/biotech-investors-in-san-francisco-bay-area/

## Method and limits
- Source: All 88 rows carry an SEC filing (Form D or Form ADV). 85 of the 88 have a website we checked; the other 3 rest on the filing or register entry alone. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule: Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states biotech and life sciences as a focus on its own site, or we observed it in the firm's portfolio. Place: head office in the San Francisco Bay Area, matched on city and state.
- Order: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stated focus on the US (15: full marks when the firm names the US as where it invests, half when it says global), size of the fund on file on a log scale (15) and completeness of the public record (10). Regional focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Fill rates: Of 88 rows: stage 65, sector 88, fund size 77, website 85. In the paid file: named decision-makers on 82 rows, firm email on 23, LinkedIn page on 40, check size on 4.

## Questions
### How many biotech investors in the San Francisco Bay Area are there?
We list 88 as of November 2026. 41 of the 88 have a fund filing or a dated deal in the last 12 months. The cities with the most are San Francisco (27), Palo Alto (16) and Menlo Park (12).

### Which biotech investors in the San Francisco Bay Area raised a new fund in the last 12 months?
29 of the 88 have a fund filing dated in the last 12 months. The most recent on this list are Future Ventures (Oct 2026), Draper Associates (Oct 2026) and Pear Ventures (Oct 2026).

### What is the typical fund size of biotech investors in the San Francisco Bay Area?
The median fund size on file for this list is $100M, across the 58 firms with a size on an SEC Form D. The fund on file is each firm's main fund, which is not always its newest. The other 30 do not disclose a size there.

### How do I contact biotech investors in the San Francisco Bay Area?
The paid file holds 434 named decision-makers across 82 of these 88 and a firm email for 23. We publish the address a firm lists itself, never a personal email. Each free row links to a profile with the firm's website.

### Where does the data on biotech investors in the San Francisco Bay Area come from?
All 88 rows have an SEC filing on file (Form D or Form ADV). Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 6 Nov 2026 at the latest. The whole file is re-verified twice a year.